"2" . "O\u0161\u0165\u00E1dal, Petr" . . . "000307827100026" . . "10.1016/j.ijcard.2012.05.053" . "RIV/00216208:11120/12:43906408!RIV13-MSM-11120___" . . "4"^^ . . "International Journal of Cardiology" . . "Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study"@en . . "[B991C0F88941]" . . . "Vondr\u00E1kov\u00E1, Dagmar" . "Vr\u00E1nov\u00E1, Jana" . "Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study" . . . . "IE - Irsko" . . "S" . "RIV/00216208:11120/12:43906408" . "Ceruloplasmin; Galectin-3; sST2; NT-proBNP; Cardiac resynchronization therapy"@en . "9"^^ . "0167-5273" . "Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study"@en . "11120" . . "159" . "Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study" . . "The objective of the present study was to assess the short-term effect of CRT on biomarkers of cardiac remodelling and fibrosis (sST2, galectin-3, NT-proBNP) together with marker of oxidative stress (ceruloplasmin). Serum levels of soluble ST2, galectin-3, NT-proBNP and ceruloplasmin were measured before and two months after CRT device implantation in 18 consecutive CRT candidates (15 men, 3 women) with device implantation between 1st January and 31st March 2011. Mean patients' age was 68 years, mean LV EF was 29%, 66% of the patients had ischemic aetiology of CHF and 33% had atrial fibrillation. Mean interval between first and second measurement was 66 days."@en . . "M\u00E1lek, Filip" . . . . "The objective of the present study was to assess the short-term effect of CRT on biomarkers of cardiac remodelling and fibrosis (sST2, galectin-3, NT-proBNP) together with marker of oxidative stress (ceruloplasmin). Serum levels of soluble ST2, galectin-3, NT-proBNP and ceruloplasmin were measured before and two months after CRT device implantation in 18 consecutive CRT candidates (15 men, 3 women) with device implantation between 1st January and 31st March 2011. Mean patients' age was 68 years, mean LV EF was 29%, 66% of the patients had ischemic aetiology of CHF and 33% had atrial fibrillation. Mean interval between first and second measurement was 66 days." . . "2"^^ . "167746" .